{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:32:14Z","timestamp":1760851934660},"reference-count":51,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":632,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2000,4]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>ABT\u2010229, a motilin agonist without antibacterial activity, has been shown to enhance both lower oesophageal sphincter pressure in cats and gastric emptying in humans.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim:<\/jats:title><jats:p>To investigate the effect of oral treatment with ABT\u2010229 10\u2003mg b.d., ABT\u2010229 5\u2003mg b.d. and cisapride 10\u2003mg q.d.s. on gastro\u2010oesophageal reflux, lower oesophageal sphincter pressure, transient lower oesophageal sphincter relaxations and symptoms in GERD patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Twenty\u2010four GERD patients completed the study. A randomized, double\u2010blind, placebo\u2010controlled, three\u2010period incomplete crossover design was used with three dosing periods of 7\u2003days. All patients received ABT\u2010229 10\u2003mg b.d. and placebo during two of the three periods. In the remaining period 12 patients were given ABT\u2010229 5\u2003mg b.d. and 12 received cisapride 10\u2003mg q.d.s. Ambulatory 24\u2003h recordings of oesophageal pH and pharyngeal, oesophageal, lower oesophageal sphincter and gastric pressures were performed on day 7 using an assembly incorporating a Dent sleeve connected to a portable water\u2010perfused manometric system.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Oesophageal acid exposure was not affected by ABT\u2010229 or cisapride, but the incidence of reflux episodes was reduced by cisapride. None of the drugs affected oesophageal motility, lower oesophageal sphincter pressure or the incidence of transient lower oesophageal sphincter relaxations. Both ABT\u2010229 10\u2003mg b.d. and cisapride reduced the severity of daytime heartburn.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>The value of ABT\u2010229 in the treatment of GERD appears to be limited.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.2000.00712.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:41:05Z","timestamp":1047354065000},"page":"453-462","source":"Crossref","is-referenced-by-count":30,"title":["The effect of motilin agonist ABT\u2010229 on gastro\u2010oesophageal reflux, oesophageal motility and lower oesophageal sphincter characteristics in GERD patients"],"prefix":"10.1111","volume":"14","author":[{"family":"Van Herwaarden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Samsom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Van Nispen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Verlinden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Smout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(86)90692-X"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.29.8.1020"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198212163072503"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199447010-00008"},{"key":"e_1_2_6_6_2","first-page":"423","article-title":"Cisapride for gastroesophageal reflux disease: a placebo\u2010controlled, double\u2010blind study","volume":"90","author":"Richter JE","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.163_b.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1159\/000200231"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01316514"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.32.11.1280"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528909091227"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529208999945"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)91089-Z"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/dote\/10.1.34"},{"key":"e_1_2_6_15_2","first-page":"561","article-title":"Effect of erythromycin on gastroesophageal reflux","volume":"15","author":"Pfeiffer A","year":"1991","journal-title":"Gastroenterol Clin Biol"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9610(94)90069-8"},{"key":"e_1_2_6_17_2","first-page":"295","article-title":"Erythromycin, motilin, and the esophagus","volume":"114","author":"Pennathur A","year":"1993","journal-title":"Surgery"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02090212"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199004123221502"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)90164-T"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02090072"},{"key":"e_1_2_6_22_2","first-page":"A80","article-title":"Erythromycin improves gastric emptying and esophageal motility without affecting gastroesophageal reflux","volume":"100","author":"Harrison ME","year":"1991","journal-title":"Gastroenterology"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.1984.247.6.G688"},{"key":"e_1_2_6_24_2","first-page":"G470","article-title":"Erythromycin is a motilin agonist","volume":"257","author":"Peeters T","year":"1989","journal-title":"Am J Physiol"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00010a024"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00260.x"},{"key":"e_1_2_6_27_2","first-page":"1891","article-title":"The motilide ABT\u2010229 increases feline lower esophageal sphincter pressure by activating neural motilin receptors","volume":"41","author":"Sifrim D","year":"1996","journal-title":"Dig Dis Sci"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.32.11.1275"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.1996.tb00263.x"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2982.1998.00093.x"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01536258"},{"key":"e_1_2_6_32_2","first-page":"113","article-title":"Cisapride: influence on oesophageal and gastric emptying and gastro\u2010oesophageal reflux in patients with reflux oesophagitis","volume":"34","author":"Collins BJ","year":"1987","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00436.x"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1993.tb00088.x"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00176.x"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.30.9.1187"},{"key":"e_1_2_6_37_2","unstructured":"PoitrasP.Motilin. In: Walsh JH Dockray GJ eds. Gut Peptides: Biochemistry and Physiology. New York: Raven Press Ltd 1994: 261\u2013304."},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02087641"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90266-X"},{"key":"e_1_2_6_40_2","first-page":"75","article-title":"Intravenous 13\u2010Nle\u2010motilin increases the human lower esophageal sphincter pressure","volume":"11","author":"Lux G","year":"1976","journal-title":"Scand J Gastroenterol"},{"key":"e_1_2_6_41_2","first-page":"A428","article-title":"Erythromycin, a motilin agonist, increases the human lower esophageal sphincter pressure in patients with systemic sclerosis","volume":"100","author":"Chaussade S","year":"1991","journal-title":"Gastroenterology"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01296657"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.29.5.631"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.31.1.21"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.26.3.246"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01537117"},{"key":"e_1_2_6_47_2","first-page":"142","article-title":"Effects of cisapride and metoclopramide on lower esophageal motility. A pressure and pH\u2010metric study","volume":"34","author":"Weiser H","year":"1986","journal-title":"Digestion"},{"key":"e_1_2_6_48_2","first-page":"1149","article-title":"Effect of cisapride on oesophageal motility and duodenogastro\u2010oesophageal reflux in patients with Barrett\u2019s oesophagus","volume":"9","author":"Smythe A","year":"1997","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1159\/000199494"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90011-X"},{"key":"e_1_2_6_51_2","first-page":"A72","article-title":"24\u2010hour ambulatory LOS pressure recording using a portable water\u2010perfused manometric system and fully automated signal analysis","volume":"10","author":"Van Herwaarden MA","year":"1998","journal-title":"Neurogastroenterol Motil"},{"key":"e_1_2_6_52_2","unstructured":"ChenWH OmariTI HollowayRH ChecklinH DentJ.A comparison of micromanometric and standard manometric techniques for recording of oesophageal motility.Neurogastroenterol Motil1998:25362."}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00712.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00712.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2000.00712.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T13:20:00Z","timestamp":1698585600000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2000.00712.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,4]]}},"alternative-id":["10.1046\/j.1365-2036.2000.00712.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2000.00712.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,4]]}}}